Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
about
Melanized fungi in human diseaseMolecular mechanism of terbinafine resistance in Saccharomyces cerevisiaeSubcutaneous hyalohyphomycosis due to Cephalotheca foveolata in an immunocompetent host.Primary central nervous system phaeohyphomycosis: a review of 101 cases.Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.Rationale for combination antifungal therapy.New developments in chemotherapy for non-invasive fungal infections.Disseminated phaeohyphomycosis: review of an emerging mycosis.Chromoblastomycosis imported from Malta.Current use of anti-infectives in dermatology.Therapy of infections caused by dematiaceous fungi.Miltefosine: oral treatment of leishmaniasis.Dematiaceous fungi.Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia.In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.A Phe389Leu substitution in ergA confers terbinafine resistance in Aspergillus fumigatusIn vitro antifungal susceptibilities of five species of sporothrixEfficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosisDisseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole.Cutaneous leishmaniasis: successful treatment with itraconazole.Phaeohyphomycosis in Transplant Patients.Comparison between two culture media for in vitro evaluation of antifungal susceptibility of the Sporothrix schenckii complex.
P2860
Q24633163-AA861BB4-D697-44B3-91F2-0094D26BC33BQ27939054-3BDBAE35-A06E-4895-BC6E-B31749EF067EQ33243626-58E3F3F6-8F3F-42AF-85F5-D88F3A6E8083Q34286912-35DDDA17-3A04-458D-8C90-E1FFD3DF6675Q34302843-E2CD44A8-630D-4442-961A-A739CE60988BQ34335236-06F86C3C-C40A-46CE-AC65-2A8EE0E69338Q34481647-F78D9496-F262-4392-98DF-61239FFFB1E9Q34498615-40C44CD2-CC6E-45BF-9F9A-899092331D64Q35209616-EE217C1B-CFCB-4E15-AD81-34A3B1010DA3Q36233506-DE9C1A9F-DEB4-410B-A63C-2407739B871BQ36233517-93A8B7BC-7880-4C98-A9A2-AC24422196D7Q36441483-9753BCF4-C3FB-43DC-98F0-A8D079D127EDQ36738130-1FE4C7F8-139B-452A-916F-E1FF284C77C4Q37351604-B643F7D6-7102-4882-88C9-83B8ADFA7F49Q38011244-DFF938D3-9395-4F25-98C7-24A9C240405EQ39989865-21FCF40F-B626-4414-825E-F742506F837BQ41474379-37103F50-DAA2-471E-9350-17DA6227A0CFQ41915091-C2B3783F-1975-410D-BD94-F361E7880463Q41931602-5A7FE8AB-A4D7-4198-96DE-EEEF6BB1949EQ44570280-7DF2CD8C-CDF9-426E-8E63-8B9030D6DACAQ46903655-09E20DA5-4D35-4AAC-8307-3F862661B9EFQ48149260-C8288077-8040-4D9C-91C3-AEDA2158977EQ50919761-D473DD97-56AF-4034-8DFB-B12AC1BF6F5D
P2860
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@ast
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@en
type
label
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@ast
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@en
prefLabel
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@ast
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@en
P1476
Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
@en
P2093
P356
10.1046/J.1365-2133.1999.00013.X
P407
P478
141 Suppl 56
P577
1999-11-01T00:00:00Z